Yuliang L. Ran

State Key Laboratory Of Molecular Oncology, Chinese Academy Of Medical Sciences And Peking Union Medical College, Chaoyang
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

High glycolysis phenotype influences malignant progression and poor prognosis of gastric cancer through the PI3K/AKT pathway.

High glycolysis phenotype influences malignant progression and poor prognosis of gastric cancer through the PI3K/AKT pathway.

Journal: Neoplasma

Published: March 21, 2025

Effects of normal mitochondrial transplantation on proliferation, apoptosis and stemness of triple-negative breast cancer cells

Effects of normal mitochondrial transplantation on proliferation, apoptosis and stemness of triple-negative breast cancer cells

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: September 18, 2024

Retraction notice to "miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1" [Life Sci. 276 (2021) 119405].

Retraction notice to "miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1" [Life Sci. 276 (2021) 119405].

Journal: Life sciences

Published: July 07, 2024

Hsp90 Promotes Gastric Cancer Cell Metastasis and Stemness by Regulating the Regional Distribution of Glycolysis-Related Metabolic Enzymes in the Cytoplasm.

Hsp90 Promotes Gastric Cancer Cell Metastasis and Stemness by Regulating the Regional Distribution of Glycolysis-Related Metabolic Enzymes in the Cytoplasm.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 22, 2023

Transcriptomic analysis and experiments revealed that remimazolam promotes proliferation and G1/S transition in HCT8 cells.

Transcriptomic analysis and experiments revealed that remimazolam promotes proliferation and G1/S transition in HCT8 cells.

Journal: Frontiers in oncology

Published: November 28, 2023

Diagnostic values of conventional tumor markers and their combination with chest CT for patients with stageⅠA lung cancer

Diagnostic values of conventional tumor markers and their combination with chest CT for patients with stageⅠA lung cancer

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: November 15, 2023

Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer.

Lipopolysaccharide promotes metastasis via acceleration of glycolysis by the nuclear factor-κB/snail/hexokinase3 signaling axis in colorectal cancer.

Journal: Cancer & metabolism

Published: February 19, 2021

Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells.

Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells.

Journal: International journal of medical sciences

Published: October 24, 2020

[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

Journal: Oncology reports

Published: December 13, 2019

Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

Journal: Oncology reports

Published: December 13, 2019

[Retracted] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

[Retracted] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.

Journal: Oncology reports

Published: December 13, 2019

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.

Journal: International journal of medical sciences

Published: May 31, 2018

Showing 1-12 of 27

Last Updated: 09/26/2026